Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program
Clinical trial NCT02582320 · COMPLETED
Trial details
- NCT number
- NCT02582320
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-10-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.